Description
Epigenetic analysis of CES1 promoter methylation status in CRPC cells with and without melatonin treatment. MLT appears to reduce DNA methylation at the CES1 locus.
Figure 15
ChartSource Paper
Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1.Cite This Figure
![Figure 15: Epigenetic analysis of CES1 promoter methylation status in CRPC cells with and without melatonin treatment. MLT appears to reduce DNA methylation at the CES1 locus.]() > Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." *Clinical and translational medicine*, 2021. PMID: [34185414](https://pubmed.ncbi.nlm.nih.gov/34185414/)
<figure> <img src="" alt="Epigenetic analysis of CES1 promoter methylation status in CRPC cells with and without melatonin treatment. MLT appears to reduce DNA methylation at the CES1 locus." /> <figcaption>Figure 15. Epigenetic analysis of CES1 promoter methylation status in CRPC cells with and without melatonin treatment. MLT appears to reduce DNA methylation at the CES1 locus.<br> Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." <em>Clinical and translational medicine</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34185414/">34185414</a></figcaption> </figure>